Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-To-Moderate Alzheimer's Disease”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00633841
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Early research (Phase 1)Study completedNCT00675090
What this trial is testing

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 28
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Large-scale testing (Phase 3)Ended earlyNCT01969123
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 474
Testing effectiveness (Phase 2)Study completedNCT00940589
What this trial is testing

Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor

Who this might be right for
Alzheimer's DiseaseSleep Disorder
Neurim Pharmaceuticals Ltd. 73
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Early research (Phase 1)Ended earlyNCT02220738
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 19
Large-scale testing (Phase 3)Ended earlyNCT01969136
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 403
Testing effectiveness (Phase 2)Looking for participantsNCT07457125
What this trial is testing

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing 33
Large-scale testing (Phase 3)WithdrawnNCT01211782
What this trial is testing

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Who this might be right for
Alzheimer's Disease
Cerecin
Not applicableStudy completedNCT02007291
What this trial is testing

Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

Who this might be right for
Late Onset Alzheimer
Federal University of Minas Gerais 71
Testing effectiveness (Phase 2)Study completedNCT00749216
What this trial is testing

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 33
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Large-scale testing (Phase 3)UnknownNCT01094340
What this trial is testing

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Banner Health 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableStudy completedNCT01746498
What this trial is testing

Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients

Who this might be right for
Alzheimer Disease
Assiut University 33
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Large-scale testing (Phase 3)Ended earlyNCT04886063
What this trial is testing

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
LeonaBio 423
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation